220 likes | 229 Views
This article explores the use of PET imaging, specifically 18F-DOPA PET and Somatostatin Receptor PET, in the clinical applications of neuroendocrine tumors. It discusses the importance of these imaging techniques in the diagnosis, staging, and monitoring of various types of neuroendocrine tumors, including pheochromocytoma and neuroblastoma. The article also highlights the use of 68Gallium DOTA-WHAT in somatostatin receptor PET.
E N D
PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti
18F-DOPA PET Somatostatin Receptor PET
CLINICAL APPLICATIONS NEUROLOGY: Movement disorders (Parkinson Disease) ONCOLOGY: Neuroendocrine tumors Pheochromocytoma Neuroblastoma (?)
F-DOPA FDG M, 59yo. Metastatic carcinoid.
F 45yo: staging of metastatic carcinoid. Several bone lesions
Male,62yo. Secondary lesions within the liver. Unknown primary.
Female,30yo. Diffuse secondary lesions within the liver. Unknown primary.
Male,52yo. Secondary lesions within the liver. Unknown primary.